1.
Rev. esp. quimioter
; 35(Supl. 3): 51-53, Oct. 2022.
Article
in English
| IBECS
| ID: ibc-210749
ABSTRACT
Ceftolozane/tazobactam, ceftazidime/avibactam and cefiderocol belong to a novel generation of antibiotics that correspond with the β-lactam family. It is necessary to having new options in treating infections caused by Gram-negative, non-fermenting multidrug-resistant bacilli due to the significant increase in multidrug resistance in the last decades. Knowing the main characteristics of each drug is key for correct use. (AU)
Subject(s)
Humans , Anti-Bacterial Agents/pharmacokinetics , Anti-Bacterial Agents/therapeutic use , beta-Lactams , Gram-Negative Bacteria , Tazobactam , Ceftazidime
2.
Gastroenterol. hepatol. (Ed. impr.)
; 44(8): 583-584, Oct. 2021. ilus
Article
in English
| IBECS
| ID: ibc-221920
3.
Gastroenterol Hepatol
; 44(8): 583-584, 2021 Oct.
Article
in English, Spanish
| MEDLINE
| ID: mdl-32718843
4.
J Rheumatol
; 47(1): 160, 2020 01.
Article
in English
| MEDLINE
| ID: mdl-31676697